), assists to clarify why KIF15 has the capacity to facilitate resistance to Eg5 inhibitors in vivo. MT gliding run by the two of such mitotic motors was arrested only when they have been independently inhibited, lending help into the proposal that a combination drug therapy focusing on these motors